Project Grant R01AI193322
Award Date 6/12/26
Completion Date 5/31/31
Dollars Obligated $941K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98109, USA
Similar Awards
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Scripps Research Institute a Project Grant of $230,000.00 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period May 1, 2026 through April 30, 2028. The award funds development of a modular cross-linker platform for proteome-scale mapping of dynamic protein-protein interactions (PPIs) in live cells using advanced cross-linking mass spectrometry (XL-MS)...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Maryland, College Park a Project Grant totaling $571,412 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 11, 2026, with a completion date of May 31, 2031. This five-year research project investigates the role of linear diribonucleotides as signaling molecules in bacterial physiology and pathogenesis. The research builds upon prior findings...
- Federal Project Grant Award Summary Protabit LLC received $304,602 in Project Grant funding from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award, effective August 7, 2025, with completion targeted for July 31, 2026, supports the development of high-throughput engineering technologies for bispecific antibodies—therapeutic molecules that combine two different antigen-binding domains. The project...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Broad Institute, Inc. a Project Grant totaling $481,250 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period August 1, 2025, through July 31, 2027. The award supports the development of novel antimicrobial compounds based on induced proximity principles. The project involves the design and creation of chimeric molecules that combine binders of...
- Federal Grant Award Summary The J. David Gladstone Institutes received a $2,047,959 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective May 11, 2026, through April 30, 2031. The grant funds the PHAIGE (Phage-Guided AI Engineering) Therapy Center, which will develop advanced preclinical assays, computational tools, and diagnostic methodologies to accelerate bacteriophage...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $899,850 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Whitehead Institute for Biomedical Research on February 20, 2026, for a five-year project period concluding January 31, 2031. This Project Grant supports fundamental research investigating how apicomplexan parasites recognize and invade host cells—a critical mechanism for parasites that depend entirely on...
- Federal Grant Award Summary Princeton University's Office of Research and Project Administration received a $451,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 23, 2025, with completion targeted for June 30, 2027. The research initiative employs chemical synthetic lethality methodology to identify novel antimicrobial targets in gram-negative bacterial...
- Federal Grant Award Summary Funding Agency: National Institute of Allergy and Infectious Diseases (NIAID) Program: Allergy and Infectious Diseases Research (CFDA 93.855) Award Amount: $463,375 Award Date: February 2, 2026 Project Period: February 2, 2026 – January 31, 2028 Harvard College's Office for Sponsored Programs is conducting high-throughput screening research to discover novel antimicrobial metabolites produced by human gut bacteria that contribute to colonization resistance—the...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $395,692 to the University of California, San Diego under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 17, 2025, for a project entitled "Enhancing Bacteriophage Function with Coevolution and Synthetic Biology." The award supports a five-year research initiative (through June 30, 2030) focused on identifying genetic modifications in bacteriophages that...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Methodist Hospital Research Institute a Project Grant of $444,125 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 8, 2025, with a completion date of July 31, 2027. This research project will characterize a previously unknown intercellular signaling pathway in Group B Streptococcus (GBS) and determine its contribution to bacterial pathogenesis. Specifically,...